Success Metrics

Clinical Success Rate
50.0%

Based on 4 completed trials

Completion Rate
50%(4/8)
Active Trials
1(9%)
Results Posted
200%(8 trials)
Terminated
4(36%)

Phase Distribution

Ph phase_4
2
18%
Ph phase_3
2
18%
Ph phase_1
2
18%
Ph phase_2
4
36%

Phase Distribution

2

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

44.4%

4 of 9 finished

Non-Completion Rate

55.6%

5 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(4)
Terminated(5)
Other(1)

Detailed Status

Completed4
Terminated4
Withdrawn1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 24 (40.0%)
Phase 32 (20.0%)
Phase 42 (20.0%)

Trials by Status

withdrawn19%
completed436%
unknown19%
terminated436%
active_not_recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
active_not_recruiting

1 vs 7 RATG Infusions in Renal Transplantation

NCT06374095
completedphase_2

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

NCT02766465
completedphase_2

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

NCT00065260
completedphase_4

Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

NCT02152345
terminatedphase_1

Stem Cell Transplantation for Stiff Person Syndrome (SPS)

NCT02282514
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06374095

1 vs 7 RATG Infusions in Renal Transplantation

Active Not Recruiting
NCT02766465Phase 2

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Completed
NCT00065260Phase 2

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Completed
NCT02152345Phase 4

Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

Completed
NCT02282514Phase 1

Stem Cell Transplantation for Stiff Person Syndrome (SPS)

Terminated
NCT03342638Phase 3

Maximizing Outcome of Multiple Sclerosis Transplantation

Terminated
NCT02102854Phase 4

Single Dose rATG for Renal Allograft Rejection

Unknown
NCT03593902Phase 2

Cardiac Safe Transplants for Systemic Sclerosis

Terminated
NCT01445821Phase 3

Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial

Terminated
NCT00787722Phase 1

Hematopoietic Stem Cell Transplant in Devic's Disease

Completed
NCT03829566Phase 2

Autologous Transplant To End NMO Spectrum Disorder

Withdrawn

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11